Attainment of low-density lipoprotein cholesterol goal after endovascular treatment is associated with reduced cardiovascular events in patients with peripheral arterial disease Jung-Hee Lee, MD, Young-Guk Ko, MD, Dong-Ho Shin, MD, MPH, Jung-Sun Kim, MD, PhD, Byeong-Keuk Kim, MD, PhD, Donghoon Choi, MD, PhD, Myeong-Ki Hong, MD, PhD, Yangsoo Jang, MD, PhD Journal of Vascular Surgery Volume 63, Issue 3, Pages 756-763 (March 2016) DOI: 10.1016/j.jvs.2015.09.059 Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Fig 1 Patient flow diagram. LDL-C, Low-density lipoprotein cholesterol. Journal of Vascular Surgery 2016 63, 756-763DOI: (10.1016/j.jvs.2015.09.059) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Fig 2 Kaplan-Meier curves for (A) major adverse cardiovascular events (MACEs), (B) all-cause mortality, and (C) cardiovascular mortality in relation to the attainment of low-density lipoprotein cholesterol (LDL-C) goal at short-term follow-up. Group A attained LDL-C <70 mg/dL; group B attained LDL-C ≥70 mg/dL. All standard errors <10%. Journal of Vascular Surgery 2016 63, 756-763DOI: (10.1016/j.jvs.2015.09.059) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Fig 3 Forest plot of subgroup analyses of major adverse cardiovascular events (MACEs). The squares and horizontal lines indicate the hazard ratios (HRs) and the 95% confidence intervals (CIs). CAD, Coronary artery disease; CKD, chronic kidney disease; CLI, critical limb ischemia; LDL-C, low-density lipoprotein cholesterol. Journal of Vascular Surgery 2016 63, 756-763DOI: (10.1016/j.jvs.2015.09.059) Copyright © 2016 Society for Vascular Surgery Terms and Conditions